Assura Plc (LON:AGR - Get Free Report) insider Jayne Cottam sold 902,389 shares of the stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of GBX 50 ($0.68), for a total transaction of £451,194.50 ($611,872.12).
Jayne Cottam also recently made the following trade(s):
- On Tuesday, August 12th, Jayne Cottam sold 1,017,587 shares of Assura stock. The shares were sold at an average price of GBX 50 ($0.68), for a total transaction of £508,793.50 ($689,983.05).
- On Tuesday, August 5th, Jayne Cottam purchased 663 shares of Assura stock. The stock was bought at an average price of GBX 49 ($0.66) per share, with a total value of £324.87 ($440.56).
- On Tuesday, July 22nd, Jayne Cottam sold 94,230 shares of Assura stock. The shares were sold at an average price of GBX 50 ($0.68), for a total transaction of £47,115 ($63,893.41).
- On Wednesday, July 9th, Jayne Cottam bought 607 shares of Assura stock. The stock was bought at an average cost of GBX 50 ($0.68) per share, for a total transaction of £303.50 ($411.58).
Assura Price Performance
Assura stock traded up GBX 0.28 ($0.00) during mid-day trading on Monday, reaching GBX 48.04 ($0.65). 57,705,824 shares of the company's stock traded hands, compared to its average volume of 29,146,250. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05. Assura Plc has a 12-month low of GBX 35.24 ($0.48) and a 12-month high of GBX 50.95 ($0.69). The company has a market cap of £1.56 billion, a price-to-earnings ratio of -45.92, a PEG ratio of 3.60 and a beta of 0.37. The stock has a 50 day moving average of GBX 49.82 and a two-hundred day moving average of GBX 47.18.
Assura (LON:AGR - Get Free Report) last announced its quarterly earnings data on Monday, July 21st. The real estate investment trust reported GBX 3.50 ($0.05) EPS for the quarter. Assura had a negative net margin of 18.09% and a negative return on equity of 1.92%. Equities analysts forecast that Assura Plc will post 3.5830389 earnings per share for the current year.
About Assura
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Further Reading
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access